Deborah Arthur

The Irish Venture Capital Association is a representative organization for venture capital and private equity firms in Ireland. The Irish company invests in private, unlisted companies with high growth potential and work with the investee company management teams to support growth plans and make improvements to the business with the aim of increasing its value. The IVCA offers a range of services to its members and benefits of membership. The company's full members are venture capital and private equity firms that provide equity funding to growing unquoted companies. Associate members of the IVCA include firms that provide advisory services including corporate finance houses, commercial and intellectual property law firms, accountants and other advisers experienced in the venture capital field.

Opsona Research Ltd. is a private company headquartered in Dublin, Ireland. The firm functions as an investment holding company.

Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland.

Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France.

Panakes Partners Sgr SpA (Panakes Partners) is a venture capital firm founded in 2015 by Alessio Beverina, Fabrizio Landi and Diana Sareceni. The firm is headquartered in Milan, Italy.

Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland.

Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The company is based in Redwood City, CA.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Gyrus Medical Ltd. manufactures medical devices. It makes instruments used in minimally invasive surgical procedures which primarily focus on products used by general surgeons. The company is located in Cardiff, UK.

Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Agilitas USA, Inc. engages in the provision of physical therapy services. The treatments it offers include dry needling therapy, manual therapy, and pelvic health speciality clinics. The company was founded by Garry Cunningham, Gregory Spurgin, and Tracy Caulkins in 1996 and is headquartered in Franklin, TN.

Ortho-Clinical Diagnostics Italy Srl manufactures and designs diagnostic, transfusion, and clinical equipment and systems. The firm provides total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. The company is headquartered in Milan, Italy.

Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom.

Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland.

Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland.